INFUSYSTEM HOLDINGS, INC Deferred State and Local Income Tax Expense (Benefit)
INFUSYSTEM HOLDINGS, INC (INFU) reported Deferred State and Local Income Tax Expense (Benefit) of $232.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-02-27
- INFUSYSTEM HOLDINGS, INC deferred state and local income tax expense (benefit) for fiscal 2025 was $232.00K, a 5.31% decline from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC deferred state and local income tax expense (benefit) for fiscal 2024 was $245.00K, a 276.92% increase from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC deferred state and local income tax expense (benefit) for fiscal 2023 was $65.00K, a 0.00% change from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC deferred state and local income tax expense (benefit) for fiscal 2022 was $65.00K.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month | Deferred State and Local Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $232.00K 10-K · filed 2026-02-27 | |
| 2024-12-31 | $245.00K 10-K · filed 2026-02-27 | |
| 2023-12-31 | $65.00K 10-K · filed 2025-03-11 | |
| 2022-12-31 | $65.00K 10-K · filed 2024-04-10 | |
| 2021-12-31 | -$3.00K 10-K · filed 2024-04-10 | |
| 2020-12-31 | -$1.73M 10-K · filed 2023-03-16 | |
| 2019-12-31 | $0.00 10-K · filed 2022-03-15 | |
| 2017-12-31 | $1.56M 10-K · filed 2019-03-22 | |
| 2016-12-31 | -$83.00K 10-K · filed 2018-03-19 | |
| 2015-12-31 | $168.00K 10-K · filed 2017-03-22 | $256.00K 10-K · filed 2016-03-09 |
| 2014-12-31 | $315.00K 10-K/A · filed 2016-12-12 | |
| 2013-12-31 | $73.00K 10-K · filed 2015-03-09 | |
| 2012-12-31 | -$191.00K 10-K · filed 2014-03-11 | |
| 2011-12-31 | -$2.41M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |